Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis

被引:16
作者
Bettiol, Alessandra [1 ]
Emmi, Giacomo [2 ]
Finocchi, Martina [2 ]
Silvestri, Elena [2 ]
Urban, Maria Letizia [2 ]
Mattioli, Irene [2 ]
Scalera, Antonella [3 ]
Lupoli, Roberta [4 ]
Vannacci, Alfredo [1 ]
Di Minno, Matteo Nicola Dario [4 ]
Prisco, Domenico [1 ]
机构
[1] NEUROFARBA, Dept Neurosci Psychol Drug Res & Child Hlth, Florence, Italy
[2] Univ Firenze, Dept Expt & Clin Med, Florence, Italy
[3] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy
[4] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
关键词
antiphospholipid syndrome; lupus anticoagulant; pregnancy; thrombosis; atherosclerosis; 1ST THROMBOTIC EVENT; FOLLOW-UP; ANTIBODIES; UPDATE; ASPIRIN;
D O I
10.1093/rheumatology/keaa116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The persistent positivity of aPLs, either isolated or associated with thrombotic and/or obstetric events (APS), has been associated with the increase of intima-media thickness (IMT) and carotid plaques. Despite the fact that aPLs can promote both thrombotic and obstetric complications, some pathogenic differences have been documented between the two entities. This study aimed to evaluate whether the atherosclerotic risk differs between subjects with obstetric and thrombotic APS. Methods. A total of 167 APS women (36 obstetric and 131 thrombotic) were compared with 250 aPLs negative controls. IMT of the common carotid artery (CCA) and of the bulb and the prevalence of carotid plaques were assessed. Results. CCA- and bulb-IMT were significantly higher in women with thrombotic APS, while being similar between the obstetric APS and the controls [CCA-IMT: mean (S.D.) 0.97 (0.49), 0.78 (0.22) and 0.81 (0.12)mm for the thrombotic, obstetric and control groups, respectively, P < 0.001 between thrombotic and controls, P = 0.002 between thrombotic and obstetric; bulb-IMT: mean (S.D.) 1.38 (0.79), 0.96 (0.27) and 0.96 (0.51)mm for the thrombotic, obstetric and control groups, P < 0.001]. Women with thrombotic APS had significantly increased risk of presenting carotid plaques. This risk was significantly lower in obstetric APS. Conclusion. Unlike thrombotic APS, obstetric APS is not associated with an increase of markers of subclinical atherosclerosis. If confirmed on wider populations, these results could suggest different pathogenetic role of aPLs in promoting atherosclerosis in vascular and obstetric APS, and raise questions on the risk-benefit profile of throm-boprophylaxis in obstetric APS outside pregnancy periods.
引用
收藏
页码:3709 / 3716
页数:8
相关论文
共 34 条
[1]   Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies [J].
Ambrosino, Pasquale ;
Lupoli, Roberta ;
Di Minno, Alessandro ;
Iervolino, Salvatore ;
Peluso, Rosario ;
Di Minno, Matteo Nicola Dario .
ANNALS OF MEDICINE, 2014, 46 (08) :693-702
[2]   Recurrent Miscarriage, Antiphospholipid Antibodies and the Risk of Thromboembolic Disease [J].
Angeles Martinez-Zamora, M. ;
Cervera, Ricard ;
Balasch, Juan .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 43 (03) :265-274
[3]   Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis [J].
Arnaud, Laurent ;
Mathian, Alexis ;
Ruffatti, Amelia ;
Erkan, Doruk ;
Tektonidou, Maria ;
Cervera, Ricard ;
Forastiero, Ricardo ;
Pengo, Vittorio ;
Lambert, Marc ;
Angeles Martinez-Zamora, Maria ;
Balasch, Juan ;
Zuily, Stephane ;
Wahl, Denis ;
Amoura, Zahir .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :281-291
[4]   Reduced plasma fibrin clot permeability and susceptibility to fibrinolysis are associated with increased intima-media thickness in patients with primary antiphospholipid syndrome [J].
Asztabski, Michal ;
Wypasek, Ewa ;
Zabczyk, Michal ;
Undas, Anetta .
THROMBOSIS RESEARCH, 2014, 134 (05) :945-951
[5]   Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients [J].
Cervera, R. ;
Khamashta, M. A. ;
Shoenfeld, Y. ;
Camps, M. T. ;
Jacobsen, S. ;
Kiss, E. ;
Zeher, M. M. ;
Tincani, A. ;
Kontopoulou-Griva, I. ;
Galeazzi, M. ;
Bellisai, F. ;
Meroni, P. L. ;
Derksen, R. H. W. M. ;
de Groot, P. G. ;
Gromnica-Ihle, E. ;
Baleva, M. ;
Mosca, M. ;
Bombardieri, S. ;
Houssiau, F. ;
Gris, J-C ;
Quere, I. ;
Hachulla, E. ;
Vasconcelos, C. ;
Roch, B. ;
Fernandez-Nebro, A. ;
Piette, J-C ;
Espinosa, G. ;
Bucciarelli, S. ;
Pisoni, C. N. ;
Bertolaccini, M. L. ;
Boffa, M-C ;
Hughes, G. R. V. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (09) :1428-1432
[6]  
Cervera R, 2017, THROMB RES, V151, pS43, DOI 10.1016/S0049-3848(17)30066-X
[7]   Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis [J].
Cheng, Chun-Yan ;
Zhang, Yi-Xin ;
Denas, Gentian ;
Du, Yao ;
Jing, Zhi-Cheng ;
Pengo, Vittorio .
INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (04) :521-527
[8]   Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study [J].
de Jesus, G. R. ;
Sciascia, S. ;
Andrade, D. ;
Barbhaiya, M. ;
Tektonidou, M. ;
Banzato, A. ;
Pengo, V. ;
Ji, L. ;
Meroni, P. L. ;
Ugarte, A. ;
Cohen, H. ;
Branch, D. W. ;
Andreoli, L. ;
Belmont, H. M. ;
Fortin, P. R. ;
Petri, M. ;
Rodriguez, E. ;
Cervera, R. ;
Knight, J. S. ;
Atsumi, T. ;
Willis, R. ;
Nascimento, I. S. ;
Rosa, R. ;
Erkan, D. ;
Levy, R. A. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 (05) :656-661
[9]   Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study [J].
Di Minno, Matteo Nicola Dario ;
Emmi, Giacomo ;
Ambrosino, Pasquale ;
Scalera, Antonella ;
Tufano, Antonella ;
Cafaro, Giovanni ;
Peluso, Rosario ;
Bettiol, Alessandra ;
Di Scala, Gerardo ;
Silvestri, Elena ;
Prisco, Domenico .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 274 :1-6
[10]   The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies [J].
Di Minno, Matteo Nicola Dario ;
Scalera, Antonella ;
Tufano, Antonella ;
Ambrosino, Pasquale ;
Bettiol, Alessandra ;
Silvestri, Elena ;
Emmi, Giacomo ;
Prisco, Domenico .
ATHEROSCLEROSIS, 2018, 278 :60-65